NUTRAORIGIN. Expanding into nutritional supplements, Divine Skin acquired rights to NutraOrigin, with 63 formulas that can be incorporated easily into any health regimen.
RANBAXY LABS. We announced a global partnership with India's largest pharmaceutical company, Ranbaxy Laboratories, to sell DS Labs products worldwide.
NANOXIDIL. The company introduced a new compound, Nanoxidil, engineered to surpass minoxidil for efficacy and tolerability. It debuted in new Spectral.DNC-N.
ASTRESSIN-B. DS Labs became the first biotech brand to commercialize a hair-growth treatment based on astressin-B, a peptide (protein fragment) newly discovered to regrow hair on bald mice. It debuted in new Spectral.F7.
CAPITALIZATION. Divine Skin secured new capital through Littlebanc Advisors to be used to build our mounting inventory and service our expanding distribution.
API SOLUTION 9. Polaris Research rolled out API Solution 9, a customizable topical kit to be sold by physicians. It delivers unprecedented concentrations of minoxidil, finasteride, and alfatradiol, and it has no competitor.
WHOLE FOODS. NutraOrigin tested successfully in Whole Foods, a chain of 297 retail stores in the United States, plus seven in Canada and six in the United Kingdom.
ZACKS INVESTMENT RESEARCH. Zacks gave Divine Skin an "outperform" rating and a six-month target price of $0.65 per share.
Divine Skin announces that its plans for expansion in 2012 are even more aggressive, and that they will further diversify its core business.
About Divine Skin
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and m
|SOURCE Divine Skin Inc.|
Copyright©2010 PR Newswire.
All rights reserved